According to Docket Navigator’s 2024 data, there has been a surge in patent cases filed in New Jersey, which has now surpassed Delaware in cases targeting generic drug makers. McCarter & English Partner Mark Makhail spoke with IAM about the reasons behind the rising case numbers across the state and said “The fact that there are no vacancies here in the District of New Jersey is also attractive to the litigants,” noting that previous vacancies had created pressure on both the court and the litigants. “The District of New Jersey has always had a strong patent bench, and with a full slate, that means cases are given all the necessary attention to assure an expeditious and correct resolution,” he added.
2.24.2025